Dynamic Bayesian Network Learning to Infer Sparse Models From Time Series Gene Expression Data
Abstract:
One of the key challenges in systems biology is to derive gene regulatory networks (GRNs) from complex high-dimensional sparse data. Bayesian networks (BNs) and dynamic Bayesian networks (DBNs) have been widely applied to infer GRNs from gene expression data. GRNs are typically sparse but traditional approaches of BN structure learning to elucidate GRNs often produce many spurious (false positive) edges. We present two new BN scoring functions, which are extensions to the Bayesian Information Criterion (BIC) score, with additional penalty terms and use them in conjunction with DBN structure search methods to find a graph structure that maximises the proposed scores. Our BN scoring functions offer better solutions for inferring networks with fewer spurious edges compared to the BIC score. The proposed methods are evaluated extensively on auto regressive and DREAM4 benchmarks. We found that they significantly improve the precision of the learned graphs, relative to the BIC score. The proposed methods are also evaluated on three real time series gene expression datasets. The results demonstrate that our algorithms are able to learn sparse graphs from high-dimensional time series data. The implementation of these algorithms is open source and is available in form of an R package on GitHub at https://github.com/HamdaBinteAjmal/DBN4GRN, along with the documentation and tutorials.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Clearance Models: Noncompartmental Models
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.


